Fermer le menu


CleveXel Pharma is an expert in diseases of the central nervous system with a unique positioning in France. Specializing in Parkinson’s disease, the Company is currently developing two first-in-class drug candidates that use innovative therapeutic approaches to overcome the limitations of current drug treatments and thus improve the quality of life of patients with Parkinson’s.


Strategic application domain: Human Medicine

Application market: Neurology & Mental Health Disorders, Oncology

Type of activity: Technology provider, Therapeutics, Pharma or Biotech

Technologies: Antibodies - Protein - Peptide, Drug delivery device & Technologies

Created on feb. 1st, 2013 - 6 employees



ICM - Hôpital Pitié-Salpêtrière
47, bd de l'Hôpital - CS21414 75646 Paris Cedex



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.